Factor This Power Engineering
Live Events
DTECH® Events
POWERGENâ¢
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Podcasts
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Longeveron Inc. - Class A Common stock
(NQ:
LGVN
)
0.5750
+0.0264 (+4.81%)
Streaming Delayed Price
Updated: 2:06 PM EST, Feb 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Longeveron Inc. - Class A Common stock
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
LGVN Shares Rise After Investigational Therapy Shows Improvement In Age-Related Frailty In Study
↗
February 25, 2026
Longeveron said that intravenous laromestrocel improved the physical condition of patients with age-related clinical frailty after nine months, compared to placebo.
Via
Stocktwits
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
November 04, 2025
Via
Benzinga
Earnings Scheduled For November 4, 2025
↗
November 04, 2025
Via
Benzinga
Earnings Preview For Longeveron
↗
November 03, 2025
Via
Benzinga
These stocks have an unusual volume in today's session
↗
August 14, 2025
Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.
Via
Chartmill
Preview: Longeveron's Earnings
↗
August 12, 2025
Via
Benzinga
Earnings Scheduled For May 8, 2025
↗
May 08, 2025
Via
Benzinga
Earnings Scheduled For November 12, 2024
↗
November 12, 2024
Via
Benzinga
A Look Ahead: Longeveron's Earnings Forecast
↗
November 11, 2024
Via
Benzinga
Peeling Back The Layers: Exploring Longeveron Through Analyst Insights
↗
November 04, 2024
Via
Benzinga
Longeveron Posts 32% Revenue Drop in Q2
↗
August 13, 2025
Via
The Motley Fool
Longeveron Inc. (NASDAQ:LGVN) Q2 2025 Earnings: Revenue Misses, EPS Narrower Than Expected
↗
August 13, 2025
Longeveron Inc. (LGVN) reported Q2 2025 earnings with revenue missing estimates at $320K but a narrower EPS loss of $0.33. Stock fell 3.5% post-earnings amid clinical progress in HLHS and Alzheimer's...
Via
Chartmill
Top stock movements in today's session.
↗
August 08, 2025
Curious to know what's happening on the US markets one hour before the close of the markets on Friday? Join us as we explore the top gainers and losers in today's session.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
August 05, 2025
Via
Benzinga
Beyond The Numbers: 4 Analysts Discuss Longeveron Stock
↗
August 27, 2024
Via
Benzinga
Earnings Scheduled For August 13, 2025
↗
August 13, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
August 04, 2025
Via
Benzinga
Which stocks are moving after the closing bell on Monday?
↗
August 04, 2025
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via
Chartmill
Longeveron® Named XPRIZE Healthspan Semifinalist and Top 40 Milestone 1 Award Recipient
May 12, 2025
From
Longeveron
Via
GlobeNewswire
Longeveron® Announces First Quarter 2025 Financial Results and Provides Business Update
May 08, 2025
From
Longeveron
Via
GlobeNewswire
Stay updated with the stocks that are on the move in today's after-hours session.
↗
February 28, 2025
After the closing bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via
Chartmill
Earnings Scheduled For February 28, 2025
↗
February 28, 2025
Via
Benzinga
Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
↗
October 28, 2024
Via
Benzinga
InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Present ‘Important’ Lomecel-B(TM) Data at the 17th Clinical Trials on Alzheimer’s Disease Conference
October 14, 2024
Via
Investor Brand Network
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) to Present at This Month’s Congenital Heart Surgeons’ Society Annual Meeting
October 09, 2024
Via
Investor Brand Network
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) CEO to Participate in Fireside Cat at UBS Virtual Organ Restoration and Cell Therapy Day
October 07, 2024
Via
Investor Brand Network
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) to Participate at the Cell & Gene Meeting on the Mesa
September 26, 2024
Via
Investor Brand Network
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Announces Alignment with FDA on Development Pathway for Lomecel-B(TM) in HLHS
September 03, 2024
Via
Investor Brand Network
InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Announces Participation at H.C. Wainwright 26th Annual Global Investment Conference
August 27, 2024
Via
Investor Brand Network
InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Reports on Q2 2024 Financial Results, Business Highlights
August 15, 2024
Via
Investor Brand Network
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
